tykhr
sign in
free sign up
Akanda Corp
Drug Manufacturers - Specialty & Generic
Healthcare
AKAN
1.04 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
3.56
52 week high
5.42
high
3.65
52 week low
0.00
low
3.50
growth
55.13 %
previous Close
3.60
P/E ratio
market cap
3.12 M
div yield
0
usd
Mar 2025
qoq
revenue
360 K
-24.60 %
net incoming
-1.41 M
47.33 %
eps
0.00 %
86.20 %
eps surprise
0.00 %
net profit margin
-392.91 %
169.00 %
operating incoming
-2.03 M
13.74 %
net change in cash
-2.19 M
-136.88 %
cash on hand
3.84 M
-36.16 %
cost of revenue
12.03 K
-98.05 %
top